Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca’s Farxiga Flies Across $1bn Barrier

Stellar Sales Of SGLT2 Inhibitor

29 Apr 2022

• By Kevin Grogan

Pascal Soriot — Pascal Soriot • Source: AstraZeneca

Related Content

AZ's COVID-19 Antibody Combo Protects For Longer But Access Issues Persist

21 Apr 2022

Boehringer Pharma Chief Confident Of Continued Success For Jardiance

12 Apr 2022

Related Companies

AstraZeneca PLC

Boehringer Ingelheim GmbH

Eli Lilly and Company

Additional Topics

Coronavirus COVID-19 Sales & Earnings Business Strategies Commercial Cardiovascular Renal BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.